Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

BRISTOL MYERS SQUIBB

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 28
  • 0 comments

FDA approve NIVOLUMAB

Comment Full text

HIKMA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 29
  • 0 comments

FDA approve DOBUTAMINE HYDROCHLORIDE

Comment Full text

TEVA PHARMS USA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 29
  • 0 comments

FDA approve METOCLOPRAMIDE HYDROCHLORIDE

Comment Full text

STRIDES PHARMA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 22
  • 0 comments

FDA approve VANCOMYCIN HYDROCHLORIDE

Comment Full text

SANDOZ INC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 31
  • 0 comments

FDA approve DENOSUMAB-BBDZ

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 29
  • 0 comments

FDA approve TOCILIZUMAB-AAZG

Comment Full text

SANDOZ INC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 30
  • 0 comments

FDA approve GILTERITINIB

Comment Full text

HERON THERAPS INC

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 31
  • 0 comments

FDA approve APREPITANT

Comment Full text

DR REDDYS LABS SA

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 27
  • 0 comments

FDA approve AMPHETAMINE SULFATE

Comment Full text

ZYDUS PHARMS

  • FDA Approval
  • March 23, 2024, 22:06 UTC
  • 28
  • 0 comments

FDA approve DEFERASIROX

Comment Full text
  • Previous
  • 513
  • 514
  • 515
  • 516
  • 517
  • Next

Search

News categories

  • Technical Exchange News(11754)
  • Event(4247)
  • SEC News(234795)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(143186)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin